Literature DB >> 10889556

Allelic distribution of CTG18.1 in Caucasian populations: association studies in bipolar disorder, schizophrenia, and ataxia.

M G McInnis1, T Swift-Scanlanl, A T Mahoney, J Vincent, G Verheyen, T H Lan, L Oruc, O Riess, C Van Broeckhoven, H Chen, J L Kennedy, D F MacKinnon, R L Margolis, S G Simpson, F J McMahon, E Gershon, J Nurnberger, T Reich, J R DePaulo, C A Ross.   

Abstract

CTG18.1 is a highly polymorphic and unstable CTG repeat within an intron of the SEF2-1 gene. We tested the CTG18.1 repeat length in affective disorder, schizophrenia, and nonspecific ataxia; these diseases all have shown clinical evidence for anticipation. There was no difference in the allele frequencies comparing the controls and disease groups. The most common allele contains 11 CAGs (35%) followed by alleles with 14-17 CAGs (35%). There was no difference in the distribution of the alleles in the cases vs controls for ataxia (P = 0.11), affective disorders (P = 0.21), or schizophrenia (P = 0.26). The frequency of unstable CTG18.1 alleles was approximately 3% in a population of N. European descent and is not related to the phenotypes tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889556     DOI: 10.1038/sj.mp.4000747

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  3 in total

Review 1.  Triplet repeats and bipolar disorder.

Authors:  Ian Jones; Katherine Gordon-Smith; Nick Craddock
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

2.  Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results.

Authors:  A L Collins; Y Kim; P Sklar; M C O'Donovan; P F Sullivan
Journal:  Psychol Med       Date:  2011-08-19       Impact factor: 7.723

Review 3.  TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease.

Authors:  Michael P Fautsch; Eric D Wieben; Keith H Baratz; Nihar Bhattacharyya; Amanda N Sadan; Nathaniel J Hafford-Tear; Stephen J Tuft; Alice E Davidson
Journal:  Prog Retin Eye Res       Date:  2020-07-28       Impact factor: 21.198

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.